Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bladder Cancer

  Free Subscription


20.01.2025

1 Am J Clin Pathol
1 Am J Transl Res
1 Anal Chem
1 Appl Biochem Biotechnol
1 Asian J Endosc Surg
1 Biol Direct
2 BJU Int
1 BMJ Case Rep
1 Cancer Discov
2 Clin Genitourin Cancer
1 Curr Opin Urol
1 Int Immunopharmacol
1 Int J Biol Macromol
1 J Clin Oncol
1 J Infect Chemother
1 J Pathol Clin Res
1 Lipids Health Dis
2 Narra J
1 Nat Genet
1 Oncology
1 Orthopedics
1 Pathol Res Pract
1 Photodiagnosis Photodyn Ther
1 Sci Rep
1 Theranostics
2 Transl Androl Urol
1 Transl Oncol
2 Urol Oncol
1 Urologie
1 Urology
2 World J Urol
1 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. KHANDAKAR H, Kaushal S, Seth A, Sahoo RK, et al
    Comparative evaluation of PD-L1 expression and tumor immune microenvironment in molecular subtypes of muscle-invasive bladder cancer and its correlation with survival outcomes.
    Am J Clin Pathol. 2025 Jan 13:aqae176. doi: 10.1093.
    PubMed         Abstract available


    Am J Transl Res

  2. YANG F, Guo Z, Wu J, Lu X, et al
    Circ-ITCH inhibits bladder cancer progression through miR-184/FOXO3 axis.
    Am J Transl Res. 2024;16:7911-7923.
    PubMed         Abstract available


    Anal Chem

  3. SONG L, Xue F, Li T, Zhang Q, et al
    Differential Diagnosis of Urinary Cancers by Surface-Enhanced Raman Spectroscopy and Machine Learning.
    Anal Chem. 2025;97:27-32.
    PubMed         Abstract available


    Appl Biochem Biotechnol

  4. ZHU C, Lin L, Huang C, Li Z, et al
    Circ-NMNAT1 Drives Tumor Progression in Bladder Cancer by Modulating the miR-370-3p/ATXN2L Axis.
    Appl Biochem Biotechnol. 2025 Jan 16. doi: 10.1007/s12010-024-05162.
    PubMed         Abstract available


    Asian J Endosc Surg

  5. MIZUNO R, Maekawa H, Hida K, Goto T, et al
    Robotic Laparoscopy and Endoscopy Cooperative Surgery for Primary Appendiceal Mucinous Carcinoma Masquerading as Bladder Cancer: A Case Report.
    Asian J Endosc Surg. 2025;18:e70021.
    PubMed         Abstract available


    Biol Direct

  6. FANG F, Wu T, Wang M, Li W, et al
    Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.
    Biol Direct. 2025;20:8.
    PubMed         Abstract available


    BJU Int

  7. OLAH C, Sichward L, Hadaschik B, Darr C, et al
    Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer.
    BJU Int. 2025 Jan 13. doi: 10.1111/bju.16643.
    PubMed         Abstract available

  8. KLUGER N, van der van der Bent SAS
    Tattoos as a risk factor for bladder cancer: a call for cohort studies.
    BJU Int. 2025 Jan 14. doi: 10.1111/bju.16648.
    PubMed        


    BMJ Case Rep

  9. SHARMA G, Shergill K, Patil M, Radcliffe R, et al
    Neuroendocrine tumour of the urinary bladder.
    BMJ Case Rep. 2025;18:e263265.
    PubMed         Abstract available


    Cancer Discov

  10. WANG X, Lee D, Xu H, Sui Y, et al
    PIN1 prolyl isomerase promotes initiation and progression of bladder cancer through the SREBP2-mediated cholesterol biosynthesis pathway.
    Cancer Discov. 2025 Jan 14. doi: 10.1158/2159-8290.CD-24-0866.
    PubMed         Abstract available


    Clin Genitourin Cancer

  11. HAN S, Li Y, Chen D, Si Z, et al
    Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort.
    Clin Genitourin Cancer. 2024;23:102280.
    PubMed         Abstract available

  12. ONISHI T, Shibahara T, Sekito S, Kato M, et al
    Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation Strategy in Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2024;23:102290.
    PubMed         Abstract available


    Curr Opin Urol

  13. CADENAR A, Mancon S, Shariat SF, D'Andrea D, et al
    Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer?
    Curr Opin Urol. 2025 Jan 17. doi: 10.1097/MOU.0000000000001261.
    PubMed         Abstract available


    Int Immunopharmacol

  14. WU Q, Lv J, Li X
    Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12/ CCL5 axis in urothelial carcinoma.
    Int Immunopharmacol. 2025;146:113802.
    PubMed         Abstract available


    Int J Biol Macromol

  15. WANG J, Li X, Zhao L, Fan X, et al
    The MCM6-c-Myc positive feedback loop mediates bladder cancer progression and cisplatin resistance.
    Int J Biol Macromol. 2025;296:139777.
    PubMed         Abstract available


    J Clin Oncol

  16. BRYAN RT, Liu W, Pirrie SJ, Amir R, et al
    Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
    J Clin Oncol. 2025 Jan 14:JCO2302398. doi: 10.1200/JCO.23.02398.
    PubMed         Abstract available


    J Infect Chemother

  17. HIYAMA Y, Shindo T, Takahashi A, Fukuta F, et al
    The incidence and risk factor for febrile urinary tract infection after robot-assisted laparoscopic radical cystectomy in bladder cancer patients.
    J Infect Chemother. 2025 Jan 15:102624. doi: 10.1016/j.jiac.2025.102624.
    PubMed         Abstract available


    J Pathol Clin Res

  18. OLAH C, Shmorhun O, Klamminger GG, Rawitzer J, et al
    Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy.
    J Pathol Clin Res. 2025;11:e70017.
    PubMed         Abstract available


    Lipids Health Dis

  19. WANG X, Li S, Li Z, Lin Z, et al
    SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of Oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase.
    Lipids Health Dis. 2025;24:14.
    PubMed         Abstract available


    Narra J

  20. SETIANINGSIH YA, Djatisoesanto W, Laksita TB, Aryati A, et al
    Diagnostic accuracy of urinary cytokeratin fragment-19 (CYFRA21-1) for bladder cancer.
    Narra J. 2024;4:e1142.
    PubMed         Abstract available

  21. HENDRI AZ, Suryawati S, Heriyanto DS, Hardianti MS, et al
    Long non-coding RNAs as prognostic biomarkers in non-muscle invasive bladder cancer: A systematic review.
    Narra J. 2024;4:e1233.
    PubMed         Abstract available


    Nat Genet

  22. WANG N, Pachai MR, Li D, Lee CJ, et al
    Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters.
    Nat Genet. 2025;57:165-179.
    PubMed         Abstract available


    Oncology

  23. ISOBE T, Naiki T, Sugiyama Y, Naiki-Ito A, et al
    Experience and Prognostic Analysis with Avelumab Switch Maintenance Treatment in Metastatic Urothelial Carcinoma.
    Oncology. 2025;103:11-21.
    PubMed         Abstract available


    Orthopedics

  24. TAGLIERO LE, Jones TL, Sherman CE, Aziz KT, et al
    Upper Extremity Mass as First Presentation of Metastatic Urothelial Carcinoma.
    Orthopedics. 2025;48:e52-e55.
    PubMed         Abstract available


    Pathol Res Pract

  25. EL SAFTAWY EA, Aboulhoda BE, AbdElkhalek MA, Alghamdi MA, et al
    Non-coding RNAs in urinary bladder cancer microenvironment: Diagnostic, therapeutic, and prognostic perspective.
    Pathol Res Pract. 2025;266:155815.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  26. CHANG G, Weijie Z, Jinying H, Bingzhang Q, et al
    Research progress of near-infrared fluorescence imaging in accurate theranostics in bladder cancer.
    Photodiagnosis Photodyn Ther. 2025 Jan 9:104480.
    PubMed         Abstract available


    Sci Rep

  27. STOOF J, Kalmoua Z, Sobota A, Brakenhoff RH, et al
    Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest.
    Sci Rep. 2025;15:2334.
    PubMed         Abstract available


    Theranostics

  28. SUN N, Zhang Z, Yang X, Li J, et al
    Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer.
    Theranostics. 2025;15:1272-1284.
    PubMed         Abstract available


    Transl Androl Urol

  29. WANG J, Zheng Q, Jian J, Chen Z, et al
    Construction of a disulfidptosis-associated lncRNA signature to predict prognosis in bladder cancer.
    Transl Androl Urol. 2024;13:2705-2723.
    PubMed         Abstract available

  30. WEDHOLM A, Wiberg E, Styrke J, Liden O, et al
    Validation of clinical T stages and of prognostic negative markers in patients with muscle invasive bladder cancer: data in the Swedish National Bladder Cancer Registry vs. data from a detailed research database.
    Transl Androl Urol. 2024;13:2757-2770.
    PubMed         Abstract available


    Transl Oncol

  31. MOKKAPATI S, Manyam G, Steinmetz AR, Tholomier C, et al
    Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.
    Transl Oncol. 2025;52:102269.
    PubMed         Abstract available


    Urol Oncol

  32. ABAZARI O, Shahidi M, Dayati P, Valizadeh S, et al
    Study of urine-based mRNA biomarkers for early detection of nonmuscle invasive bladder cancer (NMIBC).
    Urol Oncol. 2025 Jan 11:S1078-1439(24)01050.
    PubMed         Abstract available

  33. DANESHMAND S, Kamat AM, Shore ND, Meeks JJ, et al
    Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.
    Urol Oncol. 2025 Jan 15:S1078-1439(24)01044.
    PubMed         Abstract available


    Urologie

  34. RETZ M, Grimm MO, Leucht K, Zschabitz S, et al
    [Enfortumab vedotin and pembrolizumab : Management of side effects during first line combined treatment for advanced or metastatic urothelial carcinoma].
    Urologie. 2025;64:60-74.
    PubMed         Abstract available


    Urology

  35. TRIPATHY R, Kumar L, Agarwal S, Thakur A, et al
    A comparison between intravesical gemcitabine plus docetaxel and intravesical BCG in the treatment of non-muscle invasive naive urinary bladder cancer: A systematic review and meta-analysis of oncological outcomes.
    Urology. 2025 Jan 9:S0090-4295(25)00006-8. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available


    World J Urol

  36. YAMASHITA R, Sugino T, Notsu A, Ito K, et al
    Clinical outcome of BCG treatment for patients with urothelial carcinoma of the prostatic urethra: Implications for early cystectomy.
    World J Urol. 2025;43:71.
    PubMed         Abstract available

  37. AJAMI T, Musquera M, Palou J, Guru KA, et al
    A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy.
    World J Urol. 2025;43:74.
    PubMed         Abstract available


    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  38. WANG Q, Zhao L
    [Impacts of curcumin on proliferation, migration and cisplatin resistance of bladder cancer cells by regulating LKB1-AMPK-LC3 signaling pathway].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025;41:9-16.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.